Just over a year ago, Carrie Carothers was in a dark place, facing a stage 2 non-Hodgkin lymphoma (NHL) diagnosis and worried for her husband and three children. Now in remission, this philanthropic   (Read More)

OHC partners with US Oncology Research, an experienced network of more than 800 dedicated researchers who have played a role in more than 100 FDA approved cancer therapies. OHC’s leading cancer experts continue to make progress towards finding a   (Read More)

Every year, more than 25,000 Americans are diagnosed with diffuse large B-cell lymphoma (DLBCL), an aggressive cancer with a treatment journey that often poses a challenge to patients. About 30-40 percent   (Read More)

OHC advanced practice provider and lead cancer genetic specialist, Andrew “Andy” Guinigundo, MSN, RN, CNP, ANP-BC, was recently elected to the Board of Directors of the Advanced   (Read More)

According to a statement from The White House, more than 9.5 million cancer screenings in the U.S. were missed because of the COVID pandemic. Lockdowns, fear of exposure, and strained hospital resources   (Read More)

At age 71, James “Jim” Rueger, a retired attorney, had never been sick a day in his life. While enjoying one of his frequent visits to Anna Maria Island, Florida, he experienced shortness of breath and was bruising and bleeding excessively   (Read More)

Following a summer-like fall season, it is tempting to want to get outdoors and enjoy the delicate snowfall or help the grandkids build a snowman. Across the country, winter weather creates a high risk of car accidents, hypothermia and frostbite,   (Read More)

Every day, I work alongside an extremely talented and compassionate group of cancer doctors. I am pleased to learn that their brilliance has not gone unnoticed. Every year, Cincinnati Magazine surveys the city’s doctors about their   (Read More)

Cancer is a genetic disease, and about 10 percent of cancers are hereditary. At OHC, we not only treat cancer, we assess and manage the risk. Our cancer genetic specialists offer in-depth education, risk assessment, consultation, and (Read More)

According to the American Cancer Society, breast cancer is the most common cancer diagnosed among American women. About two out of three breast cancers are estrogen receptor-positive (ER+). Ongoing (Read More)

It has been a bittersweet time at OHC as our beloved Dr. Paula Weisenberger retired earlier this month after 41 years of oncology practice. Dr. Paula, as she was lovingly known by thousands, is a legacy in cancer care—a pillar in the medical   (Read More)

If you ask anyone about how they feel when thinking about the holiday season, chances are good that they will mention: joyful, grateful, celebratory, peaceful. Someone coping with the loss of a loved one to cancer will most likely experience a   (Read More)

‘Tis the holiday season, and the hustle and bustle of the preparations, decorating, shopping and celebrations is upon us. For anyone, this time of year can bring stress, fatigue, and heightened tensions, but for a cancer patient, the holidays   (Read More)

During the holiday season it’s natural to want to present the special people in our lives with the “perfect gift.” When someone we love is undergoing cancer treatment, we often find ourselves wondering (several times throughout the year) if   (Read More)

According to the Pancreatic Cancer Action Network (PanCAN), more than 60,000 Americans will be diagnosed with pancreatic cancer this year, and findings from a new study reveal that incidences are on the   (Read More)